• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证用于妊娠滋养细胞疾病辅助和研究的健康信息系统。

Development and validation of a health information system for assistance and research in gestational trophoblast disease.

机构信息

Department of Obstetrics, Universidade Federal de São Paulo, São Paulo, Brazil.

Department of Health Informatics, Universidade Federal de São Paulo, São Paulo, Brazil.

出版信息

BMC Med Inform Decis Mak. 2022 Jul 1;22(1):173. doi: 10.1186/s12911-022-01916-4.

DOI:10.1186/s12911-022-01916-4
PMID:35778727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9247895/
Abstract

BACKGROUND

Gestational Trophoblastic Disease (GTD) comprises pathological forms of placental trophoblastic tissue proliferation. When benign, they present with hydatidiform moles, and when malignant, they are called Gestational Trophoblastic Neoplasia. With the growth of the practice of digital health, allied to updated therapeutic approaches, the Outpatient Clinic for Gestational Trophoblastic Disease has built a Health Information System (HIS), contributing to the teaching-learning binomial, as well as to self-care.

METHODS

This is a cross-sectional and blind technological assessment research for developing SIS-Mola (Website for the medical team and the Application "MolaApp" aimed at patients with GTD). We used the Praxis management approach to manage the application creation project. In the tasks involving real-time chat, a WebSocket layer was created and hosted together with the project's web services, which use the Arch Linux operating system. For the evaluations, we provided questionnaires developed based on the System Usability Scale (SUS), to determine the degree of user satisfaction, with objective questions on the Likert scale. We invited 28 participants for the evaluations, among ABDTG specialist physicians, doctors from the DTG Outpatient Clinic team, and the patients. The study was systematized according to the rules of treatment and follow-up in treating the disease.

RESULTS

The tests were conducted from November 2021 to February 2022. The responses obtained on a Likert scale indicated reliability and credibility to the HIS, since the total usability score, measured by the ten questions of the SUS instrument, had a mean of 81.1 (clinicians), 80 (patients) and median of 77.5 for both groups. The sample was characterized according to the variables: age, gender, education, computer knowledge, and profession.

CONCLUSION

Developing a HIS in the GTD Outpatient Clinic met the objectives regarding the rules of treatment and follow-up of patients. With these digital tools, it is possible to obtain data about the patient's health, sending information through exams performed and appropriate treatments. The connectivity capacity allows agile care, saving time, costs and solving the displacement problem. The TICs generate natural efficiency for the organization in the flow of service and the formation of a database, improving the quality of the assistance.

摘要

背景

滋养细胞肿瘤(GTD)包括胎盘滋养层组织异常增生的病理性形式。良性时表现为葡萄胎,恶性时称为妊娠滋养细胞肿瘤。随着数字健康实践的发展,以及更新的治疗方法,妊娠滋养细胞疾病门诊建立了健康信息系统(HIS),有助于教学-学习的结合,以及自我保健。

方法

这是一项针对 SIS-Mola(针对 GTD 患者的医疗团队网站和应用程序"MolaApp")开发的横断面和盲法技术评估研究。我们使用 Praxis 管理方法来管理应用程序创建项目。在涉及实时聊天的任务中,创建了一个 WebSocket 层,并与项目的 Web 服务一起托管,这些服务使用 Arch Linux 操作系统。对于评估,我们根据系统可用性量表(SUS)开发了问卷,以确定用户满意度程度,使用李克特量表的客观问题。我们邀请了 28 名参与者进行评估,包括 ABDTG 专家医生、DTG 门诊团队医生和患者。该研究根据治疗和随访疾病的规则进行了系统化。

结果

测试于 2021 年 11 月至 2022 年 2 月进行。Likert 量表上的回答表明 HIS 具有可靠性和可信度,因为 SUS 工具的十个问题衡量的总可用性得分,临床医生为 81.1,患者为 80,两组的中位数均为 77.5。样本根据以下变量进行了特征描述:年龄、性别、教育程度、计算机知识和职业。

结论

在妊娠滋养细胞疾病门诊开发 HIS 符合患者治疗和随访的规则。通过这些数字工具,可以获取患者健康数据,通过进行检查和适当治疗发送信息。连接能力允许灵活护理,节省时间、成本并解决搬迁问题。TICs 在服务流程和数据库形成方面为组织带来自然效率,提高了援助质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/2ca33fa1460d/12911_2022_1916_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/7f939aa87cf7/12911_2022_1916_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/497fb4ae4e09/12911_2022_1916_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/53ecfbde2141/12911_2022_1916_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/bf38e1302043/12911_2022_1916_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/20a1d94a24ba/12911_2022_1916_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/c4c17579173f/12911_2022_1916_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/f2f45a934ec4/12911_2022_1916_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/2ca33fa1460d/12911_2022_1916_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/7f939aa87cf7/12911_2022_1916_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/497fb4ae4e09/12911_2022_1916_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/53ecfbde2141/12911_2022_1916_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/bf38e1302043/12911_2022_1916_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/20a1d94a24ba/12911_2022_1916_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/c4c17579173f/12911_2022_1916_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/f2f45a934ec4/12911_2022_1916_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8078/9248163/2ca33fa1460d/12911_2022_1916_Fig8_HTML.jpg

相似文献

1
Development and validation of a health information system for assistance and research in gestational trophoblast disease.开发和验证用于妊娠滋养细胞疾病辅助和研究的健康信息系统。
BMC Med Inform Decis Mak. 2022 Jul 1;22(1):173. doi: 10.1186/s12911-022-01916-4.
2
Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study.在脸书上利用在线社区为巴西妊娠滋养细胞疾病患者服务的经验:网络民族志研究
J Med Internet Res. 2018 Sep 24;20(9):e10897. doi: 10.2196/10897.
3
Experience of women on the Irish National Gestational Trophoblastic Disease Registry.爱尔兰国家妊娠滋养细胞疾病登记处女性的经历。
Eur J Obstet Gynecol Reprod Biol. 2022 May;272:206-212. doi: 10.1016/j.ejogrb.2022.03.039. Epub 2022 Mar 28.
4
Gestational trophoblastic disease- rare, sometimes dramatic, and what we know so far.妊娠滋养细胞疾病——罕见,有时病情严重,以及我们目前所了解的情况。
Semin Diagn Pathol. 2022 May;39(3):228-237. doi: 10.1053/j.semdp.2022.03.002. Epub 2022 Mar 22.
5
Guideline No. 408: Management of Gestational Trophoblastic Diseases.指南 408:妊娠滋养细胞疾病的管理。
J Obstet Gynaecol Can. 2021 Jan;43(1):91-105.e1. doi: 10.1016/j.jogc.2020.03.001.
6
Worldwide survey of the results of treating gestational trophoblastic disease.全球妊娠滋养细胞疾病治疗结果调查。
J Reprod Med. 2014 Mar-Apr;59(3-4):145-53.
7
Gestational Trophoblastic Disease: Best Practice Nursing Guidelines.妊娠滋养细胞疾病:最佳护理实践指南。
Gynecol Obstet Invest. 2024;89(3):247-253. doi: 10.1159/000530570. Epub 2023 Apr 11.
8
Differential expression of cyclin E, p63, and Ki-67 in gestational trophoblastic disease and its role in diagnosis and management: A prospective case-control study.细胞周期蛋白E、p63和Ki-67在妊娠滋养细胞疾病中的差异表达及其在诊断和管理中的作用:一项前瞻性病例对照研究。
Indian J Pathol Microbiol. 2019 Jan-Mar;62(1):54-60. doi: 10.4103/IJPM.IJPM_82_18.
9
[Gestational trophoblastic disease, Villous gestational trophoblastic disease].[妊娠滋养细胞疾病,绒毛膜性妊娠滋养细胞疾病]
Pathologe. 2004 Jul;25(4):269-79. doi: 10.1007/s00292-004-0700-y.
10
Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases.欧洲滋养细胞疾病治疗组织关于妊娠滋养细胞疾病管理的正式共识。
Eur J Cancer. 2015 Sep;51(13):1725-31. doi: 10.1016/j.ejca.2015.05.026. Epub 2015 Jun 16.

引用本文的文献

1
Expert Pathology for Gestational Trophoblastic Disease: Towards an International Multidisciplinary Team Meeting.《妊娠滋养细胞疾病的专家病理学:迈向国际化多学科团队会议》。
Gynecol Obstet Invest. 2024;89(3):166-177. doi: 10.1159/000536028. Epub 2024 Jan 8.

本文引用的文献

1
Telemedicine in post-molar follow-up: is it a useful tool?远程医疗在后摩尔随访中的应用:它是一种有用的工具吗?
Int J Gynecol Cancer. 2022 May 3;32(5):633-638. doi: 10.1136/ijgc-2021-003260.
2
FIGO Cancer Report 2021.《国际妇产科联盟2021年癌症报告》
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:5-6. doi: 10.1002/ijgo.13882.
3
Methods of usability testing in the development of eHealth applications: A scoping review.电子健康应用程序开发中的可用性测试方法:范围综述。
Int J Med Inform. 2019 Jun;126:95-104. doi: 10.1016/j.ijmedinf.2019.03.018. Epub 2019 Mar 31.
4
EVALUATION OF USABILITY OF A NEONATAL HEALTH INFORMATION SYSTEM ACCORDING TO THE USER'S PERCEPTION.根据用户认知对新生儿健康信息系统可用性的评估
Rev Paul Pediatr. 2019 Jan-Mar;37(1):90-96. doi: 10.1590/1984-0462/;2019;37;1;00019. Epub 2018 Dec 13.
5
Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study.在脸书上利用在线社区为巴西妊娠滋养细胞疾病患者服务的经验:网络民族志研究
J Med Internet Res. 2018 Sep 24;20(9):e10897. doi: 10.2196/10897.
6
PhysioDroid: combining wearable health sensors and mobile devices for a ubiquitous, continuous, and personal monitoring.生理机器人:结合可穿戴健康传感器和移动设备,实现无处不在、持续且个性化的监测。
ScientificWorldJournal. 2014;2014:490824. doi: 10.1155/2014/490824. Epub 2014 Sep 10.
7
[Challenges of the treatment of patients with gestational trophoblastic disease].[妊娠滋养细胞疾病患者的治疗挑战]
Rev Bras Ginecol Obstet. 2012 Apr;34(4):143-6.
8
[The Internet and self treatment: how to put them together?].
Hist Cienc Saude Manguinhos. 2002;9(2):291-314. doi: 10.1590/s0104-59702002000200004.